Management of toxicities of immune checkpoint inhibitors.
Spain L, Diem S, Larkin J.
Cancer Treat Rev. 2016 Mar;44:51-60. doi: 10.1016/j.ctrv.2016.02.001. Epub 2016 Feb 6.
Drug-Induced Liver Injury.
Almario EE, Borlak J, Suzuki A, Chen M.
Biomed Res Int. 2017;2017:2461694. doi: 10.1155/2017/2461694. Epub 2017 Jan 9.
[Neurotoxicity of cyclosporine].
Kozłowska I, Rózańiski J, Ciechanowski K.
Wiad Lek. 2006;59(7-8):516-20.
Cyclosporine A induced dystonia-parkinsonism.
Miklavčič P, Avčin S, Jazbec J, Vipotnik Vesnaver T, Todorova B, Trošt M, Kojović M.
J Neurol Sci. 2017 Apr 15;375:68-70. doi: 10.1016/j.jns.2017.01.043. Epub 2017 Jan 14.
Cyclosporine neurotoxicity: a review.
Gijtenbeek JM, van den Bent MJ, Vecht CJ.
J Neurol. 1999 May;246(5):339-46. doi: 10.1007/s004150050360.
Biochemical mechanisms of cyclosporine neurotoxicity.
Serkova NJ, Christians U, Benet LZ.
Mol Interv. 2004 Apr;4(2):97-107. doi: 10.1124/mi.4.2.7.
Mees' lines.
Baran R.
Br J Dermatol. 1999 Dec;141(6):1152. doi: 10.1046/j.1365-2133.1999.03236.x.
Liver transplantation today.
Busuttil RW, Goldstein LI, Danovitch GM, Ament ME, Memsic LD.
Ann Intern Med. 1986 Mar;104(3):377-89. doi: 10.7326/0003-4819-104-3-377.
A real-world disproportionality analysis of cyclosporine from the FDA Adverse Event Reporting System (FAERS) database.
Cui S, Li L, Liu W, Zhao B, Zhong X.
Braz J Med Biol Res. 2024 Jul 29;57:e13392. doi: 10.1590/1414-431X2024e13392. eCollection 2024.
Cyclosporine: a new immunosuppressive agent for organ transplantation.
Cohen DJ, Loertscher R, Rubin MF, Tilney NL, Carpenter CB, Strom TB.
Ann Intern Med. 1984 Nov;101(5):667-82. doi: 10.7326/0003-4819-101-5-667.
